History
History
History of KANEKA MEDIX
Our company was established in September 1993 as a wholly owned subsidiary of Kaneka Corporation.
Since then, we have been providing products and services that meet the specific needs of healthcare settings as a Japanese medical device manufacturer.
Kaneka entered the medical device business through blood purification.
Started sales of an adsorption type plasma purification device.
Entered into the nephrology (dialysis) field.
Established Kaneka Germany (now Kaneka Pharma Europe) in Frankfurt.
Established KANEKA MEDIX CORPORATION.
Inherited the iconic medical tubing brand SILASCON® from Dow Corning and started sales.
Started sales of a lacrimal duct tube.
Entered the ophthalmology field.
Completed the construction of the KANEKA MEDIX CORPORATION KANAGAWA PLANT.
Started sales of a PTCA balloon catheter.
Entered the cardiovascular field.
Established Kaneka Pharma America (now Kaneka Medical America LLC) in New York, USA.
Obtained FDA approval for an adsorption type plasma purification system.
Relocated Tokyo office to Tennozu.
Started sales of an adsorption type blood purification device.
Launched the TRANVAS brand.
Integrated the sales of Kaneka's intervention business into KANEKA MEDIX CORPORATION.
Established Biomaster.
Started sales of an aneurysm embolization coil.
Entered the neurosurgery field.
Started sales of a PTA balloon catheter.
Entered the vascular access intervention therapy field.
Started sales of a thrombus aspiration catheter.
Started sales of a penetration catheter.
Established KANEKA MEDIX CORPORATION Osaka Logistics Center within Kaneka Osaka Manufacturing Site.
Integrated the sales of Kaneka's blood purification business into KANEKA MEDIX CORPORATION.
Started sales of a blood flow measuring system.
Started sales of a PTA balloon catheter.
Entered the peripheral field.
Opened Cellport Clinic Yokohama.
Established Kaneka Pharma Vietnam (now Kaneka Medical Vietnam).
Established a customer service center in Tennozu.
Opened the Tokyo Logistics Center.
Relocated the Sapporo Sales Office and the Nagoya Sales Office.
Started the overseas expansion of the PTCA balloon catheter.
(Areas: EMEA, ASEAN regions, Australia, New Zealand, India)
Acquired a shareholding of River Seiko and established River Seiko.
Opened the Sendai Sales Office.
Started the overseas expansion of blood purification products (adsorption type blood purification devices).
(Areas: EMEA, North America and Central and South America)
Started the overseas expansion of the PTA balloon catheter (for peripheral vessels) (Area: China)
Started the overseas expansion of the lacrimal duct tube.
Started the overseas expansion of the aneurysm embolization coil.
(Areas: EMEA, Vietnam and Central and South America)
Opened the Hiroshima Sales Office.
Obtained FDA approval for the adsorption type blood purification device.
Started sales of a biliary dilatation balloon catheter.
Entered the gastroenterology field.
Opened the Settsu office.
Relocated the Tokyo office and the Customer Service Center to Akasaka.
Started sales of an electrode catheter.
Entered the arrhythmia field.
Changed the company name from River Seiko to KANEKA MEDICAL TECH.
Started sales of a biliary metallic stent.
Started sales of a pleural fluid/ascites concentration filter and a pleural fluid/ascites filtration filter.
Completed the construction of the new medical device plant of Kaneka Medical Vietnam.
Kaneka fully acquired Japan Medical Device Technology.
Kaneka completed the construction of Tomatoh Manufacturing Site.
Kaneka signed an exclusive distribution agreement in Japan with Israeli Company for a cerebral thrombus retriever.
Started sales of a papillotomy knife.
Started sales of a cutting type PTCA balloon.
Started sales of an intracardiac defibrillation electrode catheter.
Started sales of a cerebral infarction treatment device.